TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

Expression of the TUSC2/FUS1 tumor suppressor gene in TUSC2 deficient EGFR wildtype lung cancer cells increased sensitivity to erlotinib. Microarray mRNA expression analysis of TUSC2 inducible lung cancer cells treated with erlotinib uncovered defects in the response to oxidative stress suggesting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiaobo, Cao, Majidi, Mourad, Feng, Meng, Shao, Ruping, Wang, Jing, Zhao, Yang, Baladandayuthapani, Veerabhadran, Song, Juhee, Fang, Bingliang, Ji, Lin, Mehran, Reza, Roth, Jack A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109231/
https://www.ncbi.nlm.nih.gov/pubmed/27845352
http://dx.doi.org/10.1038/srep35741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109231/
https://www.ncbi.nlm.nih.gov/pubmed/27845352
http://dx.doi.org/10.1038/srep35741

Ejemplares similares